Literature DB >> 479481

Prostaglandin generation by human and guinea pig lung tissue: comparison of parenchymal and airway responses.

L Steel, L Platshon, M Kaliner.   

Abstract

Anaphylaxis of human lung is accompanied by the synthesis of prostaglandins (PG), including PGF2 alpha and PGE. In an analysis of the tissue source of these prostaglandins, parenchymal preparations of both human and guinea pig (GP) lungs were compared. Peripheral, relatively airway-free preparations of human lung generate PGF2 alpha and PGE in response to histamine and 2-methylhistamine, on H1 agonist, but not to dimaprit, an H2 agonist. GP parenchymal preparations respond in a similar fashion. Stimulation of these same preparations with KCl or carbachol caused no increase in the synthesis of either PG. In human airway preparations all three agonists (histamine, KCl, and carbachol) caused the selective generation of PGE. However, stimulation of GP airway preparations with the agonists caused the production of both PGE and PGF2 alpha. These data indicate that (1) human and GP peripheral lung tissues respond to H1, but not H2, stimulation with the generation of PGF2 alpha and PGE; (2) these parenchymal responses are specific and may not be attributed to muscle contraction; and (3) stimulation of muscle contraction in human airway preparations results in the selective generation of PGE while GP airways produce both PGE and PGF2 alpha.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479481     DOI: 10.1016/0091-6749(79)90146-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Lack of tachyphylaxis to histamine in both moderate and mild asthmatic subjects.

Authors:  R Polosa; J P Finnerty; S T Holgate
Journal:  Agents Actions       Date:  1990-04

Review 2.  Prostaglandins and the lung.

Authors:  S P Hanley
Journal:  Lung       Date:  1986       Impact factor: 2.584

3.  The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro.

Authors:  C A Jacques; B W Spur; M Johnson; T H Lee
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

4.  BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig.

Authors:  H P Francis; S J Greenham; U P Patel; A M Thompson; P J Gardiner
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

5.  Inhibitory actions of prostaglandin E1 on non-adrenergic non-cholinergic contraction in guinea-pig bronchi.

Authors:  T Aikawa; K Sekizawa; S Itabashi; H Sasaki; T Takishima
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

6.  Endotoxin-induced hyperreactivity of the guinea-pig isolated trachea coincides with decreased prostaglandin E2 production by the epithelial layer.

Authors:  G Folkerts; F Engels; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

7.  Preparation of a human lung purified plasma membrane fraction: confirmation by enzyme markers, electron microscopy, and histamine H1 receptor binding.

Authors:  T B Casale; M Friedman; N Parada; J Plekes; M Kaliner
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

8.  Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro.

Authors:  Z Marom; J H Shelhamer; M Kaliner
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  The effect of inhibitors of arachidonic acid metabolism on drug-induced contractions in isolated tracheal smooth muscle of the pig.

Authors:  H W Mitchell
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

10.  Time-dependent effect of prostaglandin E2 inhalation on airway responses to bronchoconstrictor agents in normal subjects.

Authors:  E H Walters; C Bevan; R W Parrish; B H Davies; A P Smith
Journal:  Thorax       Date:  1982-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.